233 related articles for article (PubMed ID: 31466934)
1. Accumulation of Hospital Days Among Antipsychotic Initiators With Alzheimer's Disease.
Koponen M; Lavikainen P; Taipale H; Tanskanen A; Tiihonen J; Hartikainen S; Tolppanen AM
J Am Med Dir Assoc; 2019 Dec; 20(12):1488-1494.e3. PubMed ID: 31466934
[TBL] [Abstract][Full Text] [Related]
2. Antiepileptic Drugs and Accumulation of Hospital Days Among Persons With Alzheimer's Disease.
Lavikainen P; Taipale H; Tanskanen A; Koponen M; Tiihonen J; Hartikainen S; Tolppanen AM
J Am Med Dir Assoc; 2019 Jun; 20(6):751-758. PubMed ID: 30630728
[TBL] [Abstract][Full Text] [Related]
3. Does Recent Hospitalization Increase Antipsychotic Initiation Among Community Dwellers With Alzheimer's Disease?
Hakala A; Tolppanen AM; Koponen M; Taipale H; Tanskanen A; Hartikainen S; Tiihonen M
J Am Med Dir Assoc; 2021 Jul; 22(7):1543-1547.e3. PubMed ID: 33460619
[TBL] [Abstract][Full Text] [Related]
4. Association of recent hospitalisation with antidepressant initiation among community dwellers with Alzheimer's disease.
Tarvainen A; Hartikainen S; Taipale H; Tanskanen A; Koponen M; Tolppanen AM
Int J Geriatr Psychiatry; 2021 Jul; 36(7):1075-1084. PubMed ID: 33527403
[TBL] [Abstract][Full Text] [Related]
5. The Risk of Head Injuries Associated With Antipsychotic Use Among Persons With Alzheimer's disease.
Tapiainen V; Lavikainen P; Koponen M; Taipale H; Tanskanen A; Tiihonen J; Hartikainen S; Tolppanen AM
J Am Geriatr Soc; 2020 Mar; 68(3):595-602. PubMed ID: 31912482
[TBL] [Abstract][Full Text] [Related]
6. Long-term use of antipsychotics among community-dwelling persons with Alzheimer׳s disease: A nationwide register-based study.
Koponen M; Taipale H; Tanskanen A; Tolppanen AM; Tiihonen J; Ahonen R; Hartikainen S
Eur Neuropsychopharmacol; 2015 Oct; 25(10):1706-13. PubMed ID: 26233607
[TBL] [Abstract][Full Text] [Related]
7. Antipsychotic Use and the Risk of Hip Fracture Among Community-Dwelling Persons With Alzheimer's Disease.
Koponen M; Taipale H; Lavikainen P; Tanskanen A; Tiihonen J; Tolppanen AM; Ahonen R; Hartikainen S
J Clin Psychiatry; 2017 Mar; 78(3):e257-e263. PubMed ID: 28146612
[TBL] [Abstract][Full Text] [Related]
8. Hospitalization after Oral Antibiotic Initiation in Finnish Community Dwellers with and without Alzheimer's Disease: Retrospective Register-Based Cohort Study.
Järvinen H; Taipale H; Koponen M; Tanskanen A; Tiihonen J; Tolppanen AM; Hartikainen S
J Alzheimers Dis; 2018; 64(2):437-445. PubMed ID: 29914029
[TBL] [Abstract][Full Text] [Related]
9. Recent Hospitalization and Initiation of Antiepileptics Among Persons With Alzheimer's Disease.
Elo J; Tolppanen AM; Koponen M; Tiihonen M; Hartikainen S
J Am Med Dir Assoc; 2023 Feb; 24(2):213-219.e6. PubMed ID: 36403662
[TBL] [Abstract][Full Text] [Related]
10. Risk for incident diabetes mellitus following initiation of second-generation antipsychotics among Medicaid-enrolled youths.
Rubin DM; Kreider AR; Matone M; Huang YS; Feudtner C; Ross ME; Localio AR
JAMA Pediatr; 2015 Apr; 169(4):e150285. PubMed ID: 25844991
[TBL] [Abstract][Full Text] [Related]
11. Impact of opioid initiation on antipsychotic and benzodiazepine and related drug use among persons with Alzheimer's disease.
Hamina A; Lavikainen P; Tanskanen A; Tolppanen AM; Tiihonen J; Hartikainen S; Taipale H
Int Psychogeriatr; 2018 Jul; 30(7):947-956. PubMed ID: 29559009
[TBL] [Abstract][Full Text] [Related]
12. Incidence of antipsychotic use in relation to diagnosis of Alzheimer's disease among community-dwelling persons.
Koponen M; Tolppanen AM; Taipale H; Tanskanen A; Tiihonen J; Johnell K; Fastbom J; Ahonen R; Hartikainen S
Br J Psychiatry; 2015 Nov; 207(5):444-9. PubMed ID: 26450581
[TBL] [Abstract][Full Text] [Related]
13. Antipsychotic polypharmacy among a nationwide sample of community-dwelling persons with Alzheimer's disease.
Taipale H; Koponen M; Tanskanen A; Tolppanen AM; Tiihonen J; Hartikainen S
J Alzheimers Dis; 2014; 41(4):1223-8. PubMed ID: 24787914
[TBL] [Abstract][Full Text] [Related]
14. Antipsychotic Use and Risk of Stroke Among Community-Dwelling People With Alzheimer's Disease.
Koponen M; Rajamaki B; Lavikainen P; Bell JS; Taipale H; Tanskanen A; Hartikainen S; Tolppanen AM
J Am Med Dir Assoc; 2022 Jun; 23(6):1059-1065.e4. PubMed ID: 34717887
[TBL] [Abstract][Full Text] [Related]
15. Nationwide study of antipsychotic use among community-dwelling persons with Alzheimer's disease in Finland.
Laitinen ML; Bell JS; Lavikainen P; Lönnroos E; Sulkava R; Hartikainen S
Int Psychogeriatr; 2011 Dec; 23(10):1623-31. PubMed ID: 21867581
[TBL] [Abstract][Full Text] [Related]
16. Risk of Mortality Associated with Antipsychotic Monotherapy and Polypharmacy Among Community-Dwelling Persons with Alzheimer's Disease.
Koponen M; Taipale H; Lavikainen P; Tanskanen A; Tiihonen J; Tolppanen AM; Ahonen R; Hartikainen S
J Alzheimers Dis; 2017; 56(1):107-118. PubMed ID: 27935554
[TBL] [Abstract][Full Text] [Related]
17. Antipsychotic Use and Risk of Hospitalization or Death Due to Pneumonia in Persons With and Those Without Alzheimer Disease.
Tolppanen AM; Koponen M; Tanskanen A; Lavikainen P; Sund R; Tiihonen J; Hartikainen S; Taipale H
Chest; 2016 Dec; 150(6):1233-1241. PubMed ID: 27298071
[TBL] [Abstract][Full Text] [Related]
18. Inpatient length of stay and atypical antipsychotic use among elderly patients with psychiatric disorders and Alzheimer's disease.
Edell WS; Rupnow MF
Manag Care Interface; 2003 May; 16(5):64-7. PubMed ID: 12789866
[TBL] [Abstract][Full Text] [Related]
19. Atypical antipsychotics for the treatment of dementia-related behaviors: an update.
Daiello LA
Med Health R I; 2007 Jun; 90(6):191-4. PubMed ID: 17633594
[TBL] [Abstract][Full Text] [Related]
20. Initiation of atypical antipsychotic agents and health outcomes in patients with schizophrenia.
Ren XS; Lee AF; Huang YH; Hamed A; Herz L; Miller DR; Kazis LE
J Clin Pharm Ther; 2004 Oct; 29(5):471-81. PubMed ID: 15482392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
